Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/13/2006 | CN1289670C Polynucleotide useful for modulating cancer cell proliferation |
12/13/2006 | CN1289664C EPSP synthase of variable halomonas high resistance glyphosate and its encoding sequence |
12/13/2006 | CN1289526C Stem cell factor |
12/13/2006 | CN1289525C T2R-novel family of taste receptors |
12/13/2006 | CN1289524C Human telomerase active inhibitor protein and use thereof |
12/13/2006 | CN1289519C Detection and identification of enteric bacteria |
12/13/2006 | CN1289073C Hair growth stimulant |
12/12/2006 | US7148338 Comprises nucleotide sequences coding oligopeptidase for use in screening compounds for treatment of cell proliferative and metabolic disorders; enzyme inhibitors |
12/12/2006 | US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors |
12/12/2006 | US7148332 High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody |
12/12/2006 | US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
12/12/2006 | US7148330 Nucleotide sequences for use in the diagnosis of inflammatory, immunological and nervous system disorders |
12/12/2006 | US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal |
12/12/2006 | US7148323 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus |
12/12/2006 | US7148321 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype |
12/12/2006 | US7148203 Plasmid for use in gene expression, mapping and mutagenesis; transposases |
12/12/2006 | US7148201 Use of human plasma hyaluronidase in cancer treatment |
12/12/2006 | US7148190 Haptotactic peprides |
12/12/2006 | US7148063 Mitochondrial creatine kinase antibody |
12/12/2006 | US7148040 Method of rapid production of hybridomas expressing monoclonal antibodies on the cell surface |
12/12/2006 | US7148038 Immunotherapy; antiproliferative agent |
12/12/2006 | US7148029 Generating antibodies; quantitative analysis |
12/12/2006 | US7148028 For diagnosis, prognosis, prophylaxis |
12/12/2006 | US7148024 Conjugates of busulfan and immunogens and antigens thereof and quantification after crosslinking |
12/12/2006 | US7148023 Immunoglobulin E detection in mammalian species |
12/12/2006 | US7148002 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
12/12/2006 | US7147858 Methods to improve immunogenicity of antigens and specificity of antibodies |
12/12/2006 | US7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein |
12/12/2006 | US7147854 Administering a monoclonal antibody which is a murine anti-human IL-8 monoclonal antibody, for treating skin inflammatory diseases |
12/12/2006 | US7147853 Nucleotide sequences codin polypeptide for use in the treatment and prevention of cell proliferative and tumor disorders |
12/12/2006 | US7147852 Methods for reducing TGF-β production and for promoting repair of liver damage |
12/12/2006 | US7147851 Humanized immunoglobulin reactive with α4β7 integrin |
12/12/2006 | US7147850 Therapeutic binding agents against MUC-1 antigen and methods for their use |
12/12/2006 | CA2245425C Neospora vaccine |
12/12/2006 | CA2201598C Vaccine compositions |
12/12/2006 | CA2167080C Prrsv recombinant proteins, diagnostic kits and vaccines containing prrs recombinant proteins |
12/12/2006 | CA2159907C A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
12/10/2006 | CA2509732A1 A method for the discrimination and isolation of mammary epithelial stem and colony-forming cells |
12/07/2006 | WO2006130834A2 IGGl ANTIBODIES WITH MUTATED FC PORTION FOR INCREASED BINDING TO FCRN RECEPTOR AND USES THEREOF |
12/07/2006 | WO2006130458A2 Antibodies directed to cd20 and uses thereof |
12/07/2006 | WO2006130022A1 Modulation of ovulation by agonists and antagonists of bmprii |
12/07/2006 | WO2006129849A1 Anti-cd14 antibody-fused protein |
12/07/2006 | WO2006129843A2 Bispecific capturing molecule |
12/07/2006 | WO2006129828A2 Target substance capturing molecule |
12/07/2006 | WO2006128715A2 Polyclonal antiserum against a universal tumor antigen |
12/07/2006 | WO2006128690A1 Anti-il2 antibodies |
12/07/2006 | WO2006128572A1 Ce46-02a insecticidal cotton |
12/07/2006 | WO2006128553A1 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, production and use thereof |
12/07/2006 | WO2006111524A3 Il-21 variants |
12/07/2006 | WO2006103494A3 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
12/07/2006 | WO2006099126A3 Biomarkers for ovarian cancer and endometrial cancer: hepcidin |
12/07/2006 | WO2006089231A3 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
12/07/2006 | WO2006089141A3 Antibodies against cxcr4 and methods of use thereof |
12/07/2006 | WO2006074399A3 Multispecific binding molecules comprising connecting peptides |
12/07/2006 | WO2006045308A3 Chlamydia trachomatis antigens for vaccine and diagnostic use |
12/07/2006 | WO2005079848A9 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders |
12/07/2006 | WO2005048822A3 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
12/07/2006 | WO2005044992A3 Fusion initiation region in rna virus envelope proteins |
12/07/2006 | WO2005035580A9 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
12/07/2006 | WO2004074454A3 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
12/07/2006 | WO2004012668A3 Sodium channel alpha subunit variants |
12/07/2006 | WO2003020913A3 Anopheles gambiae odorant receptors and genes |
12/07/2006 | US20060277629 Using expression vector comprising nucleotide sequences coding adenlylate transport protein as tool in generating plants with increased tocopherol levels |
12/07/2006 | US20060276637 Antibodies |
12/07/2006 | US20060276633 Method for the mass production of immunoglobulin constant region |
12/07/2006 | US20060276631 Antibody against a mast cell surface antigen |
12/07/2006 | US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
12/07/2006 | US20060276621 Glycosylated specificity exchangers |
12/07/2006 | US20060276375 Gpi anchored glycoprotein aca as a novel tumor marker |
12/07/2006 | US20060275871 encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs); drug screening to identify compounds which modulate the enzymatic activity of expression products |
12/07/2006 | US20060275870 Novel G-protein coupled receptors and uses therefor |
12/07/2006 | US20060275849 Monoclonal antibody reagents |
12/07/2006 | US20060275848 Diagnosis and treatment of microbacterial infections |
12/07/2006 | US20060275839 Genes |
12/07/2006 | US20060275837 At least one cysteine is replaced with seleno-cysteine or methyl-seleno-cysteine is covalently bonded to the first amino acid in the sequence; selenium analogs of the small molecule dofetilide; the peptide BeKm-1 |
12/07/2006 | US20060275831 Complement C3 precursor biopolymer markers predictive of type II diabetes |
12/07/2006 | US20060275827 non-oligomerizing Clavularia teal fluorescent protein (TFP) variant having a tyrosine-derived chromophore; nucleic acid compatible with mammalian codon usage |
12/07/2006 | US20060275804 Enzymes having dehalogenase activity and methods of use thereof |
12/07/2006 | US20060275803 Rat and mouse members of the CRISP family of genes |
12/07/2006 | US20060275790 KCNQ5, a novel potassium channel |
12/07/2006 | US20060275783 Gene markers for lung cancer |
12/07/2006 | US20060275764 Method for determining predisposition to manifestation of immune system related diseases |
12/07/2006 | US20060275759 Neuronally expressed tryptophane hydroxylase and its use |
12/07/2006 | US20060275756 Displacement assay for detecting ligate-ligand association events |
12/07/2006 | US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase |
12/07/2006 | US20060275329 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic |
12/07/2006 | US20060275323 Particles of HCV envelope proteins: use for vaccination |
12/07/2006 | US20060275318 Surface protein of leptospira |
12/07/2006 | US20060275313 Therapeutic and diagnostic agents |
12/07/2006 | US20060275311 Administering intravenous immunoglobulin for treatment and/or prophylaxis of mycobacterial infection |
12/07/2006 | US20060275310 Method and detection and decontamination of antigens by nanoparticle-raman spectroscopy |
12/07/2006 | US20060275309 Peptide oligomers for use as hiv vaccines |
12/07/2006 | US20060275307 Antibodies to treat cancer |
12/07/2006 | US20060275306 lyophilized mixture of a recombinant humanized HER2 monoclonal antibody, a lyoprotectant, and a buffer; physical and chemical stability and integrity upon lyophilization and storage; breast cancer |
12/07/2006 | US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
12/07/2006 | US20060275302 a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, a screening system |
12/07/2006 | US20060275301 Cell death-inducing agent |
12/07/2006 | US20060275300 P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof |
12/07/2006 | US20060275299 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
12/07/2006 | US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |